Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000086144 | SCV000231060 | uncertain significance | not provided | 2015-03-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000086144 | SCV001721204 | benign | not provided | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004815149 | SCV005071212 | likely benign | Retinal dystrophy | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000086144 | SCV000118288 | not provided | not provided | no assertion provided | not provided | ||
Clinical Genetics, |
RCV001705815 | SCV001926121 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000086144 | SCV001975722 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004732679 | SCV005360893 | benign | BEST1-related disorder | 2024-08-14 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |